Niche Immuno Products Target pathology labs and hospitals with Genemed's immunohistochemistry and ISH offerings for diagnostic support, tumor classification, metastasis detection, and companion diagnostics to drive personalized medicine.

SMB Market Focus With a small team and revenue under 10 million, emphasize high-touch sales, specialized training, and fast onboarding for mid-size clinics and regional pathology centers seeking niche solutions.

Global Diagnostic Demand Leverage the international demand for diagnostic pathology tools to position Genemed as a cost-effective, specialty provider that complements larger platforms from big players in the biopharma ecosystem.

Strategic Partnerships Propose collaborations with larger CROs, reference laboratories, and academic centers to expand adoption, co-develop assays, and access broader distribution channels.

Competitive Positioning Differentiate on personalized medicine support, prognostic information, and microorganism detection capabilities to capture market share among partnered diagnostic vendors and targeted therapy advocates.